Voyager Therapeut (VYGR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2006 | 12-2005 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 31,309 | 7,035 | 135 | N/A | N/A |
| Marketable Securities | 163,028 | N/A | N/A | N/A | N/A |
| TOTAL | $195,894 | $8,358 | $135 | $N/A | $N/A |
| Non-Current Assets | |||||
| PPE Net | 3,234 | 2,804 | N/A | N/A | N/A |
| Investments And Advances | 30,008 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 321 | 335 | 14 | 0 | 0 |
| TOTAL | $33,563 | $3,139 | $14 | $N/A | $N/A |
| Total Assets | $229,457 | $11,497 | $149 | $N/A | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 612 | 1,554 | 950 | 0 | 0 |
| Accrued Expenses | 3,430 | 642 | 105 | N/A | N/A |
| TOTAL | $23,931 | $2,474 | $3,982 | $N/A | $N/A |
| Non-Current Liabilities | |||||
| Deferred Revenues | 19,889 | 278 | N/A | N/A | N/A |
| Other Non-Current Liabilities | 44 | 6,560 | 0 | 0 | 0 |
| TOTAL | $36,452 | $7,874 | $N/A | $N/A | $N/A |
| Total Liabilities | $60,383 | $10,348 | $3,982 | $N/A | $N/A |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 26,749 | N/A | N/A | N/A | N/A |
| Common Shares | 25 | 1 | N/A | N/A | N/A |
| Retained earnings | -49,822 | -20,831 | -3,833 | N/A | N/A |
| Other shareholders' equity | -251 | 21,979 | 0 | 0 | 0 |
| TOTAL | $169,074 | $1,149 | $-3,833 | $N/A | $N/A |
| Total Liabilities And Equity | $229,457 | $11,497 | $149 | $0 | $0 |